New antifungal looks safer than liposomal amphotericin BBMJ 2007; 334 doi: https://doi.org/10.1136/bmj.334.7600.926-a (Published 03 May 2007) Cite this as: BMJ 2007;334:926
Micafungin is the newest in a class of antifungal agents called echinocandins. A recent trial showed that it works as well as liposomal amphotericin B, but has a significantly better safety profile when used to treat patients with invasive …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial